Sort
21,281 grants matching “influenza”
Regulation of Host Innate Immunity Against Viral Infection
$437,723Michaela Ulrike Gack · Cleveland Clinic Lerner Com-Cwru · R37 · FY2022 · AI
MOLECULAR MECHANISMS OF VIRAL MEMBRANE FUSION
$437,718Lukas K Tamm · University Of Virginia · R37 · FY2011 · AI
Emerging methods and applications for test-negative studies of of infectious disease interventions
$437,670Nicholas P Jewell · University Of California Berkeley · R01 · FY2021 · AI
Emerging methods and applications for test-negative studies of of infectious disease interventions
$437,670Nicholas P Jewell · University Of California Berkeley · R01 · FY2022 · AI
Emerging methods and applications for test-negative studies of of infectious disease interventions
$437,670Nicholas P Jewell · University Of California Berkeley · R01 · FY2023 · AI
TRIM mediated host antiviral responses during influenza virus infections
$437,546Adolfo Garcia-Sastre · University Of Southern California · U19 · FY2009 · AI
A Multi-Ethnic Faith and Public Health Partnership to Reduce Health Disparities
$437,546Kathryn Pitkin Derose · Rand Corporation · R24 · FY2015 · MD
mTOR signaling in T cell quiescence
$437,500Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2014 · AI
mTOR signaling in T cell quiescence
$437,500Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2015 · AI
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$437,500Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2018 · AI
Mechanisms of NIrp3 inflammasome activation by mitochondrial dysfunction
$437,500Suzanne L. Cassel · Cedars-Sinai Medical Center · R01 · FY2017 · AI
mTOR signaling in T cell quiescence
$437,500Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2016 · AI
mTOR signaling in T cell quiescence
$437,500Hongbo Chi · St. Jude Children'S Research Hospital · R01 · FY2017 · AI
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$437,500Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2020 · AI
Mechanisms of NIrp3 inflammasome activation by mitochondrial dysfunction
$437,500Suzanne L. Cassel · Cedars-Sinai Medical Center · R01 · FY2018 · AI
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$437,500Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2019 · AI
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$437,500Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2016 · AI
Unique aspects of respiratory immunity
$437,500Troy D Randall · Trudeau Institute, Inc. · R01 · FY2006 · HL
ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
$437,500Childrens Hospital Of Philadelphia · R01 · FY2005 · AI
Memory T cell subsets and pulmonary immunity
$437,500David L Woodland · Trudeau Institute, Inc. · R01 · FY2006 · AI
ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
$437,500Childrens Hospital Of Philadelphia · R01 · FY2004 · AI
ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
$437,500Children'S Hospital Of Philadelphia · R01 · FY2003 · AI
Targeting the NLRP3 inflammasome to limit pathologic sterile inflammation
$437,500Fayyaz S. Sutterwala · Cedars-Sinai Medical Center · R01 · FY2017 · AI
ENHANCING MUCOSAL IMMUNE RESPONSES BY MICROENCAPSULATION
$437,500Children'S Hospital Of Philadelphia · R01 · FY2002 · AI
Sublingual Supramolecular Vaccines and Immunotherapies
$437,499Joel H Collier · Duke University · R01 · FY2023 · AI